Registered number: 02728640 | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
FOR THE YEAR ENDED 31 DECEMBER 2016 | ||||||||
|
||||||||
Prepared By: | ||||||||
Simon Coles & Co | ||||||||
Chartered Accountants | ||||||||
PO Box 600 | ||||||||
London | ||||||||
WC1H 0XB |
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 31 DECEMBER 2016 | ||||||||
DIRECTORS | ||||||||
|
||||||||
REGISTERED OFFICE | ||||||||
|
||||||||
|
||||||||
East Sussex | ||||||||
|
||||||||
COMPANY DETAILS | ||||||||
Private company limited by shares registered in EW - England and Wales, registered number 02728640 | ||||||||
ACCOUNTANTS | ||||||||
Simon Coles & Co | ||||||||
Chartered Accountants | ||||||||
PO Box 600 | ||||||||
London | ||||||||
WC1H 0XB |
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 31 DECEMBER 2016 | ||||||||
CONTENTS | ||||||||
Page | ||||||||
Directors' Report | - | |||||||
Accountants' Report | - | |||||||
Statement Of Comprehensive Income | - | |||||||
Balance Sheet | 3 | |||||||
Notes To The Accounts | 4 | |||||||
The following do not form part of the statutory financial statements: | ||||||||
Trading And Profit And Loss Account | - | |||||||
Profit And Loss Account Summaries | - |
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
BALANCE SHEET AT
|
||||||||||
2016 | 2015 | |||||||||
Notes | £ | £ | ||||||||
FIXED ASSETS | ||||||||||
Tangible assets | 2 |
|
|
|||||||
CURRENT ASSETS | ||||||||||
Stock | 402,592 | 370,293 | ||||||||
Debtors | 4 | 235,798 | 142,629 | |||||||
Cash at bank and in hand |
|
|
||||||||
638,390 | 512,983 | |||||||||
CREDITORS: Amounts falling due within one year | 5 | 511,493 | 277,998 | |||||||
NET CURRENT ASSETS | 126,897 | 234,985 | ||||||||
TOTAL ASSETS LESS CURRENT LIABILITIES | 975,407 | 1,040,004 | ||||||||
CREDITORS: Amounts falling due after more than one year | 6 | 272,861 | 307,779 | |||||||
PROVISIONS FOR LIABILITIES AND CHARGES | 8 | 14,000 | - | |||||||
NET ASSETS | 688,546 | 732,225 | ||||||||
CAPITAL AND RESERVES | ||||||||||
Called up share capital | 9 | 140 | 140 | |||||||
Share premium account | 10 | 39,990 | 39,990 | |||||||
Revaluation reserve | 1f,11 | 297,877 | 311,877 | |||||||
Profit and loss account | 350,539 | 380,218 | ||||||||
SHAREHOLDERS' FUNDS |
|
732,225 | ||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on
|
||||||||||
............................. | ||||||||||
|
||||||||||
Director | ||||||||||
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
NOTES TO THE ACCOUNTS | ||||||||||
FOR THE YEAR ENDED 31 DECEMBER 2016 | ||||||||||
1. ACCOUNTING POLICIES |
1a. Basis Of Accounting | ||||||||
The accounts have been prepared under the historical cost convention. | ||||||||
The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . |
1b. Depreciation | ||||||||
|
||||||||
Land And Buildings | reducing balance 15% | |||||||
Plant and Machinery | reducing balance 25% | |||||||
Equipment | reducing balance 25% |
1c. Stocks | ||||||||
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs. | ||||||||
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs. |
1d. Pension Costs | ||||||||
The company operates a defined contribution pension scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme. |
1e. Foreign Currency | ||||||||
Transactions in currencies, other than the functional currency of the company, are recorded at the rate of the exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. All differences are taken to the profit and loss account. Non-monetary items that are measured at the historic cost in a foreign currency are not retranslated. |
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
1f. Revaluation Reserve | ||||||||
Surpluses or deficits arising on the revaluation of individual fixed assets other than investment properties are credited or debited to a non-distributible reserve known as the revaluation reserve (see also note 11 ). | ||||||||
Revaluation deficits in excess of the amount of prior revaluation surpluses on the same asset are charged to the profit and loss account. |
2. TANGIBLE FIXED ASSETS | ||||||||
Land And | Plant and | |||||||
Buildings | Machinery | Equipment | Total | |||||
£ | £ | £ | £ | |||||
Cost | ||||||||
At 1 January 2016 | 888,342 | 33,450 | 106,339 | 1,028,131 | ||||
Additions | 82,657 | - | 1,650 | 84,307 | ||||
At 31 December 2016 | 970,999 | 33,450 | 107,989 | 1,112,438 | ||||
Depreciation | ||||||||
At 1 January 2016 | 136,508 | 9,283 | 77,321 | 223,112 | ||||
For the year | 27,521 | 6,042 | 7,253 | 40,816 | ||||
At 31 December 2016 | 164,029 | 15,325 | 84,574 | 263,928 | ||||
Net Book Amounts | ||||||||
At 31 December 2016 |
|
|
|
|
||||
At 31 December 2015 |
|
|
|
|
||||
3. STOCK | 2016 | 2015 | ||||
£ | £ | |||||
Stock comprises: | ||||||
Stock |
|
|
||||
|
|
4. DEBTORS | 2016 | 2015 | ||||||
£ | £ | |||||||
Amounts falling due within one year | ||||||||
Trade debtors | 122,321 | 103,248 | ||||||
UK corporation tax | 13,414 | - | ||||||
Other debtors | 808 | - | ||||||
Prepayments | 25,075 | 20,963 | ||||||
Directors current account | 74,180 | 18,418 | ||||||
235,798 | 142,629 | |||||||
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
2016 | 2015 | |||||||
£ | £ | |||||||
UK corporation tax | - | 10,999 | ||||||
VAT | 731 | 32,851 | ||||||
PAYE control | 13,067 | 8,106 | ||||||
Salaries and wages control | 1,136 | - | ||||||
Bank loans and overdrafts | 330,366 | 139,162 | ||||||
Trade creditors | 161,716 | 42,000 | ||||||
Other creditors | 4,477 | 3,625 | ||||||
Accruals | - | 41,255 | ||||||
511,493 | 277,998 | |||||||
6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR | ||||||||
2016 | 2015 | |||||||
£ | £ | |||||||
Mortgage loans (secured) >1yr | 272,861 | 307,779 | ||||||
272,861 | 307,779 | |||||||
These are secured against the company's Freehold property. | ||||||||
7. EMPLOYEES | ||||||
2016 | 2015 | |||||
No. | No. | |||||
Average number of employees | 11 | 12 | ||||
8. PROVISIONS FOR LIABILITIES | 2016 | 2015 | ||||||
£ | £ | |||||||
Deferred taxation | 14,000 | - | ||||||
14,000 | - | |||||||
|
||||||||
SIMPLANTEX HEALTHCARE LIMITED | ||||||||
|
9. SHARE CAPITAL | 2016 | 2015 | ||||||
£ | £ | |||||||
Allotted, issued and fully paid: | ||||||||
|
140 | 140 | ||||||
140 | 140 | |||||||
10. SHARE PREMIUM ACCOUNT | 2016 | 2015 | ||||
£ | £ | |||||
Share premium account | 39,990 | 39,990 |
11. REVALUATION RESERVE | 2016 | 2015 | ||||||
£ | £ | |||||||
Revaluation reserve | 297,877 | 311,877 | ||||||
297,877 | 311,877 | |||||||
12. RELATED PARTY TRANSACTIONS | ||||||||
1. At the year end, other debtors included an amount of £74,180 ( previous year £18,418) due from Mr O I Askaroff, the director. | ||||||||